CRYSTAL DUPRE': Open Payments
NPI 1346741170 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 59 payments from 16 companies in 2025. Trend: 2023 $76 · 2024 $110 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $165 |
| AstraZeneca Pharmaceuticals LP | 9 | $157 |
| Amgen Inc. | 11 | $143 |
| Lilly USA, LLC | 6 | $92 |
| PFIZER INC. | 3 | $55 |
| Edwards Lifesciences Corporation | 2 | $46 |
| Ardelyx, Inc. | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $31 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Abbott Laboratories | 1 | $26 |
Products named: AIRSUPRA, Wegovy, MOUNJARO, EVENITY, OTEZLA, PREVNAR 20, Ozempic, IBSRELA.
Industry payments across LA — which companies pay providers there.
